Literature DB >> 8947477

Production of the R2 subunit of ribonucleotide reductase from herpes simplex virus with prokaryotic and eukaryotic expression systems: higher activity of R2 produced by eukaryotic cells related to higher iron-binding capacity.

N Lamarche1, G Matton, B Massie, M Fontecave, M Atta, F Dumas, P Gaudreau, Y Langelier.   

Abstract

The R2 subunit of ribonucleotide reductase from herpes simplex virus type 2 was overproduced with prokaryotic and eukaryotic expression systems. The recombinant R2 purified by a two-step procedure exhibited a 3-fold higher activity when produced in eukaryotic cells. Precise quantification of the R2 concentration at each step of the purification indicated that the activity was not altered during the purification procedure. Moreover, we have observed that the level of R2 expression, in eukaryotic cells as well as in prokaryotic cells, did not influence R2 activity. Extensive characterization of the recombinant R2 purified from eukaryotic and prokaryotic expression systems has shown that both types of pure R2 preparations were similar in their 76 kDa dimer contents (more than 95%) and in their ability to bind the R1 subunit. However, we have found that the higher activity of R2 produced in eukaryotic cells is more probably related to a higher capability of binding the iron cofactor as well as a 3-fold greater ability to generate the tyrosyl free radical.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8947477      PMCID: PMC1217907          DOI: 10.1042/bj3200129

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  Expression in bacteria of a polypeptide encoded by a transforming fragment of herpes simplex virus type 2.

Authors:  M Danik; M Suh
Journal:  Cancer Detect Prev       Date:  1991

Review 2.  The redox centers of ribonucleotide reductase of Escherichia coli.

Authors:  M Fontecave; P Nordlund; H Eklund; P Reichard
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1992

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Herpes simplex virus ribonucleotide reductase subunit association inhibitors: the effect and conformation of beta-alkylated aspartic acid derivatives.

Authors:  N Moss; R Déziel; J M Ferland; S Goulet; P J Jones; S F Leonard; T P Pitner; R Plante
Journal:  Bioorg Med Chem       Date:  1994-09       Impact factor: 3.641

6.  The critical C-terminus of the small subunit of herpes simplex virus ribonucleotide reductase is mobile and conformationally similar to C-terminal peptides.

Authors:  S R Laplante; N Aubry; M Liuzzi; L Thelander; R Ingemarson; N Moss
Journal:  Int J Pept Protein Res       Date:  1994-12

7.  A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo.

Authors:  M Liuzzi; R Déziel; N Moss; P Beaulieu; A M Bonneau; C Bousquet; J G Chafouleas; M Garneau; J Jaramillo; R L Krogsrud
Journal:  Nature       Date:  1994-12-15       Impact factor: 49.962

8.  Iron and free radical in ribonucleotide reductase. Exchange of iron and Mössbauer spectroscopy of the protein B2 subunit of the Escherichia coli enzyme.

Authors:  C L Atkin; L Thelander; P Reichard; G Lang
Journal:  J Biol Chem       Date:  1973-11-10       Impact factor: 5.157

9.  Amino acid misincorporation during high-level expression of mouse epidermal growth factor in Escherichia coli.

Authors:  C A Scorer; M J Carrier; R F Rosenberger
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

10.  Cloning of the vaccinia virus ribonucleotide reductase small subunit gene. Characterization of the gene product expressed in Escherichia coli.

Authors:  M L Howell; J Sanders-Loehr; T M Loehr; N A Roseman; C K Mathews; M B Slabaugh
Journal:  J Biol Chem       Date:  1992-01-25       Impact factor: 5.157

View more
  6 in total

1.  Determination of the in vivo stoichiometry of tyrosyl radical per betabeta' in Saccharomyces cerevisiae ribonucleotide reductase.

Authors:  Allison D Ortigosa; Daniela Hristova; Deborah L Perlstein; Zhen Zhang; Mingxia Huang; JoAnne Stubbe
Journal:  Biochemistry       Date:  2006-10-10       Impact factor: 3.162

2.  White spot syndrome virus protein kinase 1 defeats the host cell's iron-withholding defense mechanism by interacting with host ferritin.

Authors:  Shin-Jen Lin; Der-Yen Lee; Hao-Ching Wang; Shih-Ting Kang; Pung-Pung Hwang; Guang-Hsiung Kou; Ming-Fen Huang; Geen-Dong Chang; Chu-Fang Lo
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

3.  The ribonucleotide reductase R1 subunits of herpes simplex virus 1 and 2 protect cells against poly(I · C)-induced apoptosis.

Authors:  Florent Dufour; Luc Bertrand; Angela Pearson; Nathalie Grandvaux; Yves Langelier
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

Review 4.  Manipulation of iron to determine survival: competition between host and pathogen.

Authors:  Nihay Laham; Rachel Ehrlich
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

5.  HF-EPR, Raman, UV/VIS light spectroscopic, and DFT studies of the ribonucleotide reductase R2 tyrosyl radical from Epstein-Barr virus.

Authors:  Ane B Tomter; Giorgio Zoppellaro; Florian Schmitzberger; Niels H Andersen; Anne-Laure Barra; Henrik Engman; Pär Nordlund; K Kristoffer Andersson
Journal:  PLoS One       Date:  2011-09-27       Impact factor: 3.240

6.  2,3,7,8-Tetrachlorodibenzo-p-dioxin promotes BHV-1 infection in mammalian cells by interfering with iron homeostasis regulation.

Authors:  Filomena Fiorito; Carlo Irace; Antonio Di Pascale; Alfredo Colonna; Giuseppe Iovane; Ugo Pagnini; Rita Santamaria; Luisa De Martino
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.